Emergency Medicine · Toxicology
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Classic toxidrome: mad as a hatter, blind as a bat, red as a beet, hot as a hare, and dry as a bone.
Most commonly caused by diphenhydramine, tricyclic antidepressants, or Jimson weed.
Anhidrosis (dry skin) is the key finding distinguishing it from sympathomimetic toxicity, which causes diaphoresis.
Obtain an immediate ECG to screen for QRS widening >100 ms signaling life-threatening TCA toxicity.
First-line treatment is supportive care with benzodiazepines for agitation and seizures plus active cooling.
The antidote physostigmine is reserved for severe pure anticholinergic delirium without TCA involvement.
Physostigmine is absolutely contraindicated in suspected TCA overdose due to the risk of precipitating asystole.
Vignette unlocked
A 19-year-old woman is brought in after ingesting an unknown quantity of an over-the-counter sleep aid. She is agitated and picking at the air, with dilated pupils, flushed dry skin, and a temperature of 39.4°C. Her heart rate is 132/min and bowel sounds are absent. A 12-lead ECG shows a normal QRS duration of 88 ms.
Which of the following is the most appropriate antidote for her condition?
Physostigmine.
The patient has anticholinergic toxidrome (likely from diphenhydramine) with delirium, mydriasis, anhidrosis, and hyperthermia, and the normal QRS duration excludes TCA sodium-channel toxicity. Physostigmine, a reversible acetylcholinesterase inhibitor, is appropriate here but would be contraindicated if QRS widening suggested TCA overdose.
Full handout
High yield triage
Etiology / Epidemiology
Caused by competitive antagonism of muscarinic acetylcholine receptors, most commonly via diphenhydramine, tricyclic antidepressants, or Jimson weed.
Clinical Manifestations
Presents with the classic toxidrome: mad as a hatter, blind as a bat, red as a beet, hot as a hare, and dry as a bone.
Diagnosis
A clinical diagnosis requiring an immediate ECG to screen for prolonged QRS indicative of lethal TCA toxicity.
Treatment
Managed primarily with supportive care and benzodiazepines for agitation, reserving physostigmine for severe cases without TCA involvement.
Prognosis
Generally favorable with supportive care, but severe cases risk hyperthermic seizures, rhabdomyolysis, and fatal arrhythmias.
Full handout
Epidemiology & Etiology
Results from intentional overdose or accidental ingestion of agents blocking muscarinic receptors. Common culprits include first-generation antihistamines like diphenhydramine, tricyclic antidepressants, antipsychotics, and antiparkinsonian drugs like benztropine. Plant ingestions, notably Datura stramonium (Jimson weed) and Atropa belladonna (deadly nightshade), are classic board scenarios. Polypharmacy in the elderly significantly increases the risk of this toxidrome due to the cumulative anticholinergic burden and decreased renal/hepatic clearance.
Pertinent Anatomy
Peripheral symptoms arise from blockade at postganglionic parasympathetic nerve terminals innervating the heart, smooth muscle, and exocrine glands. Central symptoms originate from the blockade of muscarinic receptors within the cerebral cortex and brainstem, profoundly disrupting cognitive processing and arousal. Impaired thermoregulation stems directly from the inability to stimulate eccrine sweat glands in the dermis.
Pathophysiology
Agents cause competitive, reversible antagonism of acetylcholine at muscarinic receptors. Peripheral M2 blockade at the SA node abolishes vagal tone, leading to profound tachycardia. M3 blockade prevents eccrine sweat gland activation, causing anhidrosis and subsequent failure of evaporative cooling, resulting in hyperthermia. Central muscarinic blockade disrupts neurotransmission, precipitating agitated delirium, hallucinations, and seizures.
Clinical Manifestations
The presentation is defined by the classic mnemonic: mad as a hatter (agitated delirium, picking at the air), blind as a bat (mydriasis and loss of accommodation), red as a beet (compensatory cutaneous vasodilation), hot as a hare (hyperthermia), and dry as a bone (anhidrosis and dry mucous membranes). Patients frequently exhibit full as a flask (urinary retention) and decreased or absent bowel sounds. Absent sweating is the critical physical exam finding distinguishing this from sympathomimetic toxicity.
Diagnosis
This is primarily a clinical diagnosis based on history and pathognomonic physical exam findings. The gold standard initial test is a 12-lead ECG to evaluate for QRS widening > 100 ms or a terminal R wave in aVR, which indicates sodium channel blockade from life-threatening TCA toxicity. Laboratory evaluation should include a basic metabolic panel, creatine kinase to rule out rhabdomyolysis, and a urine pregnancy test in females. Comprehensive urine drug screens are generally unhelpful for acute management and frequently yield false positives.
Treatment
First-line treatment is supportive, utilizing rapid cooling measures and intravenous benzodiazepines (e.g., lorazepam) for agitation and seizures. Gastrointestinal decontamination with activated charcoal is indicated if the patient presents within 1-2 hours of ingestion and has a protected airway. The specific antidote physostigmine (a reversible acetylcholinesterase inhibitor) is reserved for severe central delirium or hyperthermia unresponsive to standard therapy. However, physostigmine is absolutely contraindicated in suspected TCA overdose due to the high risk of precipitating irreversible asystole.
Prognosis
Most patients recover completely within 24-48 hours as the offending agent is metabolized and cleared. Prolonged toxicity can occur because anticholinergic agents slow gastric emptying, leading to delayed drug absorption. Severe complications requiring aggressive monitoring include hyperthermia-induced rhabdomyolysis, status epilepticus, and cardiovascular collapse.
Differential Diagnosis
1. Sympathomimetic toxidrome: Presents with tachycardia and hyperthermia, but features profound diaphoresis rather than anhidrosis.
2. Serotonin syndrome: Features altered mental status and hyperthermia, but is distinguished by lower extremity hyperreflexia and clonus.
3. Neuroleptic malignant syndrome (NMS): Distinguished by lead-pipe muscle rigidity and a history of dopamine antagonist use.
4. Salicylate toxicity: Presents with altered mental status and hyperthermia, but features tachypnea (primary respiratory alkalosis) and tinnitus.